Bipolar Depression: Clinical Trials

190 trials for Bipolar Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

114 completed, 21 recruiting, 19 unknown, 17 terminated. 57 Not applicable, 44 Phase 3, 41 Phase 2, 27 Phase 4, 12 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable57Completed 28, Recruiting 11, Unknown 9, Terminated 5, Active not recruiting 2, Not yet recruiting 1, Suspended 1
Phase 344Completed 30, Recruiting 4, Terminated 3, Unknown 3, Active not recruiting 2, Suspended 1, Withdrawn 1
Phase 241Completed 24, Terminated 7, Withdrawn 4, Unknown 3, Recruiting 2, Active not recruiting 1
Phase 427Completed 18, Withdrawn 3, Recruiting 2, Terminated 2, Unknown 2
Phase 112Completed 6, Active not recruiting 1, Recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1
Early Phase 15Completed 3, Active not recruiting 1, Unknown 1

Follow Bipolar Depression: new trials by email Literature Review of Bipolar Depression trials Research Report on Bipolar Depression

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Feasibility of DBS for Bipolar Depression
Medtronic Percept PC DBS system - Bipolar I Disorder, Bipolar Depression
Not applicableRecruitingIcahn School of Medicine at Mount Sinai52026-09-212026-09-22
PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder
Nutritional intervention - Bipolar Depression, Bipolar Disorder (BD)
Not applicableRecruitingUniversity of Sao Paulo882026-04-012026-03-02
Empagliflozin Adjunctive Therapy in Bipolar Depression
Empagliflozin (EMPA) - Bipolar Disorder, Bipolar Depression
Not applicableNot yet recruitingUniversity of Sao Paulo202026-03-092026-03-16
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
Vortioxetine, Cariprazine (Augmentation Phase) - Unipolar Depression, Bipolar Depression
Phase 4RecruitingMayo Clinic1202026-02-172026-06-22
Dopamine D3 Receptor Occupancy in Bipolar Depression
Cariprazine - Bipolar Depression
Phase 4WithdrawnNew York State Psychiatric Institute2026-01-062026-04-14
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
Electroconvulsive Therapy - Major Depression Moderate, Major Depression Severe
RecruitingIstanbul University - Cerrahpasa622025-12-012026-07-31
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Azetukalner - Bipolar Depression, Bipolar I Disorder
Phase 3Active not recruitingXenon Pharmaceuticals Inc.4002025-10-302026-10-13
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Active HD-tDCS, Antipsychotics, mood stabilizers, etc., Sham HD-tDCS - Adolescent, Bipolar Depression
Not applicableRecruitingJiangsu Province Nanjing Brain Hospital1002025-09-162025-11-24
Ketogenic Intervention for Bipolar Depression
Ketogenic Diet - Bipolar Depression
Not applicableRecruitingMayo Clinic302025-08-122026-08-17
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Azetukalner, Placebo - Bipolar Disorder, Bipolar Depression
Phase 3Active not recruitingXenon Pharmaceuticals Inc.4002025-08-082026-10-13
SYNCED - SYNChronized Eating in Bipolar Depression Study
Time restricted eating, Eating ad libitum with nutritional counselling - Bipolar Depression, Bipolar I Disorder
Not applicableRecruitingUniversity of Ottawa402025-07-102026-05-01
Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
ExAblate Neuro 4000 - Treatment-Resistant Depression, Bipolar Depression
Not applicableRecruitingSunnybrook Health Sciences Centre102025-06-252025-08-06
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
Temporal Interference Stimulation, Sham Temporal Interference Stimulation - Bipolar Depression
Not applicableRecruitingFirst Affiliated Hospital of Zhejiang University1602025-05-202026-05-27
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder
Phase 3RecruitingDr. Inge Winter12542025-04-272026-01-22
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Escitalopram, Sertraline, Venlafaxine - Bipolar Depression
Phase 3RecruitingDr. Inge Winter4182025-02-112025-09-26
Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
Medtronic Percept RC System, One Month Blinded Discontinuation Period - Bipolar Depression
Not applicableRecruitingWayne Goodman MD102025-01-012026-01-26
FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression
Ketamine, Functional magnetic resonance imaging (fMRI) - Bipolar Depression, Treatment Resistant Bipolar Depression
Phase 2CompletedDrew Cumming202024-11-122026-10-15
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
Psilocybin, Functional MRI - Bipolar Depression
Phase 1Active not recruitingUniversity Health Network, Toronto302024-10-092026-08-10
Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression
deep Transcranial Magnetic Stimulation (dTMS) -active, deep Transcranial Magnetic Stimulation (dTMS) -sham - Bipolar Depression
Not applicableRecruitingTianjin Anding Hospital1002024-08-012026-02-27
Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder
Temporal Interference Stimulation - Bipolar Depression
Not applicableCompletedFirst Affiliated Hospital of Zhejiang University362024-07-162026-05-27

Showing 20 of 190. Sign in to see all of them.

Narrower conditions

Bipolar Disorder (190)  ·  Depression (61)  ·  Depressive Disorder, Major (26)  ·  Depressive Disorder (19)  ·  Depressive Disorder, Treatment-Resistant (12)  ·  Mood Disorders (10)  ·  Suicidal Ideation (10)  ·  Anxiety Disorders (3)  ·  Cognitive Dysfunction (2)  ·  Inflammation (2)  ·  Insulin Resistance (2)  ·  Mania (2)  ·  Mental Disorders (2)  ·  Metabolic Syndrome (2)  ·  Schizophrenia (2)

Broader conditions

Bipolar and Related Disorders (189)  ·  Mental Disorders (188)  ·  Mood Disorders (180)  ·  Behavior (69)  ·  Behavioral Symptoms (68)  ·  Depressive Disorder (29)  ·  Self-Injurious Behavior (11)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Suicide (9)  ·  Nervous System Diseases (7)  ·  Signs and Symptoms (7)  ·  Neurologic Manifestations (6)  ·  Metabolic Diseases (4)  ·  Neurobehavioral Manifestations (4)  ·  Nutritional and Metabolic Diseases (4)

Interventions

Ketamine (16)  ·  Lurasidone Hydrochloride (12)  ·  Quetiapine Fumarate (10)  ·  Lithium (9)  ·  Lamotrigine (6)  ·  Transcranial Magnetic Stimulation (5)  ·  Valproic Acid (5)  ·  lumateperone (5)  ·  Escitalopram (4)  ·  Midazolam (4)  ·  Minocycline (4)  ·  Therapeutics (4)  ·  Ultraviolet Therapy (4)  ·  Sertraline (3)  ·  cariprazine (3)

Sponsors

Mclean Hospital (12)  ·  AstraZeneca (9)  ·  Intra-Cellular Therapies, Inc. (5)  ·  Massachusetts General Hospital (5)  ·  Mayo Clinic (5)  ·  NeuroRx, Inc. (5)  ·  Sumitomo Pharma America, Inc. (5)  ·  University of Sao Paulo (5)  ·  Centre for Addiction and Mental Health (4)  ·  New York State Psychiatric Institute (4)  ·  University Health Network, Toronto (4)  ·  First Affiliated Hospital of Zhejiang University (3)  ·  Indiana University (3)  ·  Medical University of South Carolina (3)  ·  National Institute of Mental Health (NIMH) (3)

Countries

United States (102)  ·  Canada (28)  ·  Russia (10)  ·  Ukraine (10)  ·  China (9)  ·  Spain (9)  ·  Brazil (7)  ·  Colombia (7)  ·  France (6)  ·  Germany (6)  ·  India (6)  ·  Poland (6)  ·  Serbia (6)  ·  South Korea (6)  ·  Bulgaria (5)

Top investigators

Amit Anand, MD (4)  ·  Susan Kozauer, MD (4)  ·  Joshua Rosenblat, MD, MSc (3)  ·  Martin Brecher, MD (3)  ·  Andrew Nierenberg, MD (2)  ·  Beth L Murphy, MD, PhD (2)  ·  Brent P Forester, MD (2)  ·  Daniel Blumberger, MD, MSc (2)  ·  Declan M McLoughlin, PhD (2)  ·  Gregory Sahlem, MD (2)  ·  Lori L Davis, MD (2)  ·  Mark Frye, MD (2)  ·  Nassir Ghaemi, MD, MPH (2)

Results publications

PMID 41017591, PMID 14702256, PMID 20854181, PMID 26730454, PMID 27215976, PMID 27529375, PMID 34510411, PMID 37339360, PMID 39098761, PMID 41401709, PMID 15780843, PMID 17229469, PMID 19956089, PMID 20074703, PMID 20122366, PMID 20122369, PMID 20136801, PMID 21034692, PMID 21808751, PMID 22545088, PMID 22827578, PMID 23059166, PMID 23364679, PMID 24170180, PMID 24170221, PMID 24331545, PMID 24699040, PMID 24715548, PMID 25340384, PMID 25522399, PMID 25721187, PMID 25844756, PMID 26363720, PMID 26911380, PMID 27089521, PMID 27366831, PMID 28706563, PMID 29111077, PMID 29146409, PMID 29673379, PMID 30102967, PMID 30172724, PMID 30184133, PMID 30466205, PMID 30524702, PMID 31066887, PMID 31630035, PMID 31923551, PMID 31969269, PMID 32055965

NIH funding

2016 (2), 1UH3NS136631 (1), 2018 (1), 2019 (1), 2023 (1), K23MH077287 (1), R01MH078060 (1), R01MH079261 (1), R01MH090276 (1), T32DA022975 (1)